Molecular imaging can allow the non-invasive assessment of biological and biochemical
processes in living subjects. Such technologies therefore have the potential to enhance our …

Positron-Emission Tomography and Assessment of Cancer Therapy | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …

Revised Response Criteria for Malignant Lymphoma Page 1 Revised Response Criteria for
Malignant Lymphoma Bruce D. Cheson, Beate Pfistner, Malik E. Juweid, Randy D. Gascoyne …

Background It is unclear whether patients with early-stage Hodgkin's lymphoma and
negative findings on positron-emission tomography (PET) after three cycles of …

Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of
the Imaging Subcommittee of International Page 1 Use of Positron Emission Tomography for …

Purpose Starting from November 2001, 260 newly diagnosed patients with Hodgkin's
lymphoma (HL) were consecutively enrolled in parallel Italian and Danish prospective trials …

Risk-adapted lymphoma treatment requires early and accurate assessment of prognosis.
This investigation prospectively assessed the value of positron emission tomography with 2 …

[18F] Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …

Novel molecular imaging techniques have the potential to significantly enhance the
diagnostic and therapeutic approaches for cancer treatment. For solid tumors in particular …

Assessment of early therapeutic response using metabolic imaging is potentially useful to
determine prognosis in aggressive lymphoma. Between January 2000 and January 2004 …